The European Medicines Agency (EMA) has started evaluating an application for the use of a booster dose of the COVID-19 vaccine of Johnson&Johnson (Janssen), which would be given at least two months after the first dose to people aged 18 years and older.
EMA’s human medicines committee (CHMP) will carry out an accelerated assessment of data submitted by the company that markets the vaccine.
The data include results from more than 14,000 adults who received a second dose of COVID-19 Vaccine Janssen or placebo (a dummy treatment) two months after the initial dose.
Source: Cyprus News Agency